U.S. markets closed

Healixa Inc. (EMOR)

Other OTC - Other OTC Delayed Price. Currency in USD
Add to watchlist
0.6500-0.0900 (-12.16%)
At close: 3:21PM EDT
Full screen
Trade prices are not sourced from all markets
Gain actionable insight from technical analysis on financial instruments, to help optimize your trading strategies
Chart Events
Neutralpattern detected
Previous Close0.7400
Open0.7100
Bid0.0000 x 0
Ask0.0000 x 0
Day's Range0.6000 - 0.7100
52 Week Range0.5600 - 3.0500
Volume10,703
Avg. Volume14,090
Market Cap50.694M
Beta (5Y Monthly)N/A
PE Ratio (TTM)N/A
EPS (TTM)N/A
Earnings DateN/A
Forward Dividend & YieldN/A (N/A)
Ex-Dividend DateN/A
1y Target EstN/A
Fair Value is the appropriate price for the shares of a company, based on its earnings and growth rate also interpreted as when P/E Ratio = Growth Rate. Estimated return represents the projected annual return you might expect after purchasing shares in the company and holding them over the default time horizon of 5 years, based on the EPS growth rate that we have projected.
Fair Value
XX.XX
N/A
Research that delivers an independent perspective, consistent methodology and actionable insight
Related Research
View more
  • Marble Arch Research, Inc. Initiates Research Coverage of Healixa Inc.
    GlobeNewswire

    Marble Arch Research, Inc. Initiates Research Coverage of Healixa Inc.

    Holbrook, New York, May 17, 2021 (GLOBE NEWSWIRE) -- Healixa, Inc. (OTC Pink: EMOR) (“Healixa”, or the “Company”), a healthcare technology company delivering seamless and instant virtual care from your smartphone by combining healthtech and fintech to offer digital pharmacy, virtual patient monitoring and digital pharmacy subscription services, is very pleased to announce that Marble Arch Research Inc., a leading independent equity research provider, has produced a new investment research report on the Company. The initiation report provides an overview of recent events, new initiatives, as well as a recent acquisition in the space which favorably impacts the company valuation relative to its peer group. The sponsored research also carries a rating and a price target and can be accessed at https://emerginggrowth.com/marble-arch-research-report-healixa-inc-otc-pink-emor/ In the update report released today, Marble Arch Research notes that, “Using a comps-based valuation approach, we believe EMOR should be trading at $2.8-$3.3 per share vs the prevailing $1.20. Acknowledging that Healixa is in the very early stages of commercializing its virtual care ecosystem, we place a Speculative Buy recommendation on the stock, but put it on watch to a possible upgrade to a firm BUY as we monitor the company’s early operational progress, moves towards a main board uplisting...” About Healixa Inc. Healixa Inc., formerly known as Emerald Organic Products Inc., is a technology company with assets in both healthtech and fintech. Healixa marries code and care to create exceptional experiences in healthtech. The Company’s people-first approach is designed to humanize care via purpose-driven ethical engineering practices, deploying simple solutions for complex global challenges. Healixa offers value-based tech solutions to enterprise partner channels across a broad range of industries including employer benefits, travel, pharma, logistics and more. Forward-looking Statements Certain statements contained in this press release may constitute forward-looking statements. For example, forward-looking statements are used when discussing our expected research and development programs, and more. These forward-looking statements are based only on current expectations of management and are subject to significant risks and uncertainties that could cause actual results to differ materially from those described in the forward-looking statements, including but not limited to the risks and uncertainties related to the progress, timing, cost, and results of Partnerships and product development programs; difficulties or delays in obtaining regulatory approval or patent protection; and competition from other companies. Except as otherwise required by law, Healixa Inc., f.k.a. Emerald Organic Products, Inc., undertakes no obligation to publicly release any revisions to these forward-looking statements to reflect events or circumstances after the date hereof or to reflect the occurrence of unanticipated events. CONTACT: Kirin M. Smith PCG Advisory, Inc. 1-646-823-8656 ksmith@pcgadvisory.com

  • Rideshare Relationship Gives Healixa National Reach
    GlobeNewswire

    Rideshare Relationship Gives Healixa National Reach

    Established Rideshare Network Expedites Healixa’s Ability to Service Customers NationwideHolbrook, New York, May 11, 2021 (GLOBE NEWSWIRE) -- Healixa, Inc. (OTC Pink: EMOR) (“Healixa”, or the “Company”), a healthcare technology company delivering seamless and instant virtual care from your smartphone by combining healthtech and fintech to offer digital pharmacy, virtual patient monitoring and digital pharmacy subscription services, announces today that its new global rideshare relationship will enable “last-mile” delivery services of prescriptions directly to the customers’ doorsteps nationwide. By launching with a global rideshare operation, Healixa expedites its ability to service customers in almost any large metropolitan area and quickly penetrate those markets. The testing program, which has been successfully underway, tested all of the systems necessary to deliver on demand and batch scripts in a large metropolitan area. This gave Healixa the data needed to assess logistical resources needed, as well as test for bugs and exceptions in the delivery process and user experience. Following the success of the testing program, the next step will be to launch last-mile delivery services in various large metropolitan areas including Healixa’s own newly acquired pharmacy ecosystem. Ian Parker, CEO of Healixa, Inc. commented, “In the last several weeks, we have been asked repeatedly how Healixa will be able to logistically deliver patient scripts throughout the country. Launching with an established rideshare network solves that part of the puzzle and gives us the ability to go national (or even global) rapidly. In order to compete with the Amazons of the world, Healixa must be able to deliver nationally through an established network of drivers, and we have that now.” About Healixa Inc. Healixa Inc., formerly known as Emerald Organic Products Inc., is a technology company with assets in both healthtech and fintech. Healixa marries code and care to create exceptional experiences in healthtech. The Company’s people-first approach is designed to humanize care via purpose-driven ethical engineering practices, deploying simple solutions for complex global challenges. Healixa offers value-based tech solutions to enterprise partner channels across a broad range of industries including employer benefits, travel, pharma, logistics and more. Forward-looking Statements Certain statements contained in this press release may constitute forward-looking statements. For example, forward-looking statements are used when discussing our expected research and development programs, and more. These forward-looking statements are based only on current expectations of management and are subject to significant risks and uncertainties that could cause actual results to differ materially from those described in the forward-looking statements, including but not limited to the risks and uncertainties related to the progress, timing, cost, and results of Partnerships and product development programs; difficulties or delays in obtaining regulatory approval or patent protection; and competition from other companies. Except as otherwise required by law, Healixa Inc., f.k.a. Emerald Organic Products, Inc., undertakes no obligation to publicly release any revisions to these forward-looking statements to reflect events or circumstances after the date hereof or to reflect the occurrence of unanticipated events. CONTACT: Kirin M. Smith PCG Advisory, Inc. 1-646-823-8656 ksmith@pcgadvisory.com

  • Emerald Organic Products Inc. Announces Name Change to Healixa Inc. Effective Wednesday, April 28, 2021
    GlobeNewswire

    Emerald Organic Products Inc. Announces Name Change to Healixa Inc. Effective Wednesday, April 28, 2021

    New Name Reflects the Company’s Healing MissionHolbrook, New York, April 28, 2021 (GLOBE NEWSWIRE) -- Healixa Inc. (OTC: EMOR) (the “Company”, or "Healixa"), a people-first digital organization that humanizes care by deploying simplified solutions for complex global challenges, today announces that it has received notice from FINRA that prior to the commencement of trading today, Wednesday, April 28, 2021, the Company’s name will have been changed from Emerald Organic Products Inc. (the “Former Name”) to Healixa Inc. (the “Updated Name”). There will be no change to the symbol, the Company’s common shares will continue to trade under the ticker “EMOR” on the OTC markets. The CUSIP number assigned to the Company’s shares following the name change to the Updated Name is 57387H105. No action is required to be taken by shareholders with respect to the name change. Outstanding share certificates are not affected by the name change and do not need to be exchanged. “The name of our stock will now reflect the healing technologies that our team has worked hard to design, develop and deploy,” commented Ian Parker, CEO of Healixa Inc. “The market has yet to see the full extent of our healing technologies as they are set to be revealed over the coming months.” The new name more accurately reflects the Company’s mission to democratize access to healing technologies by developing superior and innovative products, services, and offerings around our digital on-demand ecosystem. “The name Healixa will become synonymous with ethically engineered, paradigm shifting technologies that will impact the world around us in a profound and positive way,” added Parker. About Emerald Organic Products Inc. Emerald Organic Products Inc. has recently changed its name to Healixa, Inc. in the State of Nevada and continues to trade under the symbol OTC: EMOR. The name change will be reflected as of April 28, 2021 on the OTC ticker board. About Healixa Inc. Healixa is a technology company with assets in both healthtech and fintech. Healixa marries code and care to create exceptional experiences in healthtech. The Company’s people-first approach is designed to humanize care via purpose-driven ethical engineering practices, deploying simple solutions for complex global challenges. Healixa offers value-based tech solutions to enterprise partner channels across a broad range of industries including employer benefits, travel, pharma, logistics and more. Forward-looking Statements Certain statements contained in this press release may constitute forward-looking statements. For example, forward-looking statements are used when discussing our expected research and development programs, and more. These forward-looking statements are based only on current expectations of management and are subject to significant risks and uncertainties that could cause actual results to differ materially from those described in the forward-looking statements, including but not limited to the risks and uncertainties related to the progress, timing, cost, and results of Partnerships and product development programs; difficulties or delays in obtaining regulatory approval or patent protection; and competition from other companies. Except as otherwise required by law, Healixa Inc., f.k.a. Emerald Organic Products, Inc., undertakes no obligation to publicly release any revisions to these forward-looking statements to reflect events or circumstances after the date hereof or to reflect the occurrence of unanticipated events. CONTACT: Kirin M. Smith PCG Advisory, Inc. 1-646-823-8656 ksmith@pcgadvisory.com